Information for
Shareholders and Investors
Stock market information
Stock market information
Additionally, the Company has a Loyalty Double Voting Rights Share Register, which records 13,344,556 shares with recognized double voting rights, so that the total number of voting rights in the Company amounts to 48.281.467. There are no pending applications awaiting completion of the legally established period required to acquire loyalty double voting rights.
Share capital
3.493.691,10 €
€0.10 / share, Nº. of shares: 34.936.911
Significant shareholders
| % voting rights attached to shares | % voting rights through financial instruments | % total voting rights | Notification history | |||||
|---|---|---|---|---|---|---|---|---|
| % Total | % Direct | % Indirect | % (B) | (A+B) | CNMV filing date | Additional information | Details / cancellations | |
| Pablo Martín Rodríguez | 61,921 | 0,000 | 61,921 | 0,000 | 61,921 | 07/10/2025 | ||
| Pablo Arnús de Soto | 3,749 | 0,000 | 3,749 | 0,000 | 3,749 | 10/07/2025 | ||
Economic and financial information
Key figures
Total revenue
Normalised EBITDA
Employees
Net profit
Pending future data
EBITDA margin / Revenue
Pending future data
Financial statements
Annual Financial Statements
Interim financial statements
Financial reports
Non-financial information statement
Earnings presentation
Issuance of promissory notes on the MARF
Average payment period to suppliers
The company calculates the average payment period to suppliers in accordance with applicable commercial regulations and in accordance with the legally established methodology.
Complete information regarding this indicator is included in the Company’s annual financial statements for the most recent fiscal year, which are available for review in the financial information section of this website.
Ratings and Analyst Coverage
Corporate governance
Board of Directors
Directors
Pablo Martín Rodríguez
Chairman and Chief Executive Officer
Lourdes Argüelles García
Executive Board Member
Manuel Rodríguez Pasarín
Executive Board Member
Diego Ramón Cabezudo Fernández de la Vega
Independent Member to the Board of Directors and Chairman of the Audit Committee
Arturo José Diaz Dapena
Proprietary Member to the Board of Directors and Member of the Audit Committee
Carlos Emilio Sartorius Witte
Independent Member to the Board of Directors
Juan Carlos Ureta Domingo
Independendent Member to the Board of Directors
Pablo Arnús de Soto
Proprietary Member to the Board of Directors
Irene Sáenz De Santa María Valín
Non-Director Secretary
Carla Carrio Quilligan
Deputy Non-Director Secretary
General Shareholders' Meeting
Articles of association and bylaws
Corporate policies
Communications to the CNMV
Inside information
Other relevant information
Documentation and prospectuses
Investor Calendar
Junta General de Accionistas
Publicación a cierre de Mercado
28 Mayo 2026
Foro Medcap BME
Publicación a cierre de Mercado
28 Mayo 2026
Resultados FY 2025
Publicación a cierre de Mercado
26 Febrero 2026
Resultados FY 2025
Publicación a cierre de Mercado
26 Febrero 2026
Investor Relations
For more information, please visit:
Avenida Jardín Botánico, 1345. C.P. 33203, Gijón
985 16 38 91
